Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARRERA, IMMACULADA | 2 | 28.6% | +83.3% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.3% | +48.6% |
| SAOUD, CHRISTINE J | 1 | 57.8% | +37.9% |
| PARK, HAEJIN S | 1 | 55.3% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17914868 | RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF | BARRERA, IMMACULADA | 19d |
| 18554972 | RECOMBINANT NEWCASTLE DISEASE VIRUS RNDV-VEGF-TRAP, GENOME THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | BARRERA, IMMACULADA | 23d |
| 18005237 | PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | TOWNSLEY, SARA ELIZABETH | 71d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920163 | APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION TO PREPARATION OF MEDICINE FOR TREATING OR PREVENTING CORONAVIRUS INFECTION | PARK, HAEJIN S | 114d overdue |
| 17999903 | RHFGF21 FUSION PROTEIN, POLYNUCLEOTIDE ENCODING RHFGF21 FUSION PROTEIN, COMPOSITION CONTAINING RHFGF21 FUSION PROTEIN, AND USE OF RHFGF21 FUSION PROTEIN | SAOUD, CHRISTINE J | 7d |
| 17914868 | RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF | BARRERA, IMMACULADA | 19d |
| 18554972 | RECOMBINANT NEWCASTLE DISEASE VIRUS RNDV-VEGF-TRAP, GENOME THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | BARRERA, IMMACULADA | 23d |
| 18005237 | PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | TOWNSLEY, SARA ELIZABETH | 71d |
| Art Unit | Apps |
|---|---|
| 1671 | 2 |
| 1629 | 1 |
| 1645 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18554972 | RECOMBINANT NEWCASTLE DISEASE VIRUS RNDV-VEGF-TRAP, GENOME THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | BARRERA, IMMACULADA | 1671 | Other | Non-Final OA | 23d | Pending | Oct 11, 2023 |
| 18005237 | PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | TOWNSLEY, SARA ELIZABETH | 1629 | §103 | Final Rejection | 71d | Pending | Jan 12, 2023 |
| 17999903 | RHFGF21 FUSION PROTEIN, POLYNUCLEOTIDE ENCODING RHFGF21 FUSION PROTEIN, COMPOSITION CONTAINING RHFGF21 FUSION PROTEIN, AND USE OF RHFGF21 FUSION PROTEIN | SAOUD, CHRISTINE J | 1645 | §103 | Non-Final OA | 7d | Pending | Nov 25, 2022 |
| 17920163 | APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION TO PREPARATION OF MEDICINE FOR TREATING OR PREVENTING CORONAVIRUS INFECTION | PARK, HAEJIN S | 1614 | §103 | Non-Final OA | 114d overdue | Pending | Oct 20, 2022 |
| 17914868 | RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD THEREFOR, RECOMBINANT PLASMID, AND USE THEREOF | BARRERA, IMMACULADA | 1671 | §112 | Final Rejection | 19d | Pending | Sep 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial